SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-088393
Filing Date
2021-03-22
Accepted
2021-03-22 06:36:55
Documents
16
Period of Report
2021-03-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d112331d8k.htm   iXBRL 8-K 36366
2 EX-99.1 d112331dex991.htm EX-99.1 22999
6 GRAPHIC g112331ex99_1p1g1.jpg GRAPHIC 430393
7 GRAPHIC g112331ex99_1p2g1.jpg GRAPHIC 134138
8 GRAPHIC g112331ex99_1p3g1.jpg GRAPHIC 164297
  Complete submission text file 0001193125-21-088393.txt   1199987

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20210322.xsd EX-101.SCH 3075
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20210322_lab.xml EX-101.LAB 18839
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20210322_pre.xml EX-101.PRE 11842
9 EXTRACTED XBRL INSTANCE DOCUMENT d112331d8k_htm.xml XML 3535
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 21759849
SIC: 2834 Pharmaceutical Preparations